Assembly Bio is an ambitious biopharmaceutical company based in South San Francisco, CA, dedicated to transforming the treatment of serious viral diseases. With cutting-edge therapeutic clinical candidates and research programs, they aim to improve the lives of millions living with chronic hepatitis B virus (HBV) infection and other devastating viral diseases.
Their team of experienced professionals, including their CEO Jason Okazaki and Chief Scientific Officer William Delaney, PhD, is committed to advancing treatment options through the discovery and development of novel antivirals, with the goal of delivering finite and curative therapies for HBV and progressing differentiated research programs for serious viral diseases.
Generated from the website